Direct prion transmission likely predominates during breeding season, but indirect interactions may be more common at socially attractive sites such as scrapes, the authors say.
Watch a webinar on findings and recommendations from CIDRAP's report on CWD spillover preparedness and response. Experts discuss key One Health topics followed by a Q&A session moderated by CIDRAP Director Dr. Michael Osterholm.
The report provides useful guidance to professionals at human, animal, and wildlife health agencies; academic researchers; and medical practitioners who will be tasked with responding to any human or non-cervid animal chronic wasting disease spillover.
The CIDRAP CWD Resource Center hosts webinars featuring natural and international experts.
Our monthly roundup features the latest CWD-related news, research, and events.
Stay in touch with CIDRAP CWD via X for the latest news and research.
Keep current with CIDRAP CWD news and research on Bluesky.
Receive CWD updates in your inbox
High-risk adults with mild to moderate COVID-19 who receive a dose of casirivimab and imdevimab have lower hospitalization rates than those who don't, according to a randomized, controlled trial today in The Lancet's EClinicalMedicine. The casirivimab and imdevimab combination is under emergency use authorization by the US Food and Drug Administration.
Out of 574 multiple-occupancy dorm rooms, roommate transmissions occurred only 20% of the time, according to a study during the fall 2020 semester at the University of Colorado Boulder.
Chronic wasting disease (CWD) has been detected in an adult deer found dead in early May in the Wisconsin city of Brooklyn, marking the state's first such case in Green Lake County, the Wisconsin Department of Natural Resources (WDNR) said late last week.
COVID-19 infection was 94% less likely in people previously infected than in those never infected, according to a research letter late last week in JAMA Internal Medicine. However, the researchers note, their study concluded before COVID-19 variants became dominant.
The Global Antibiotic Research and Development Partnership (GARDP), on behalf of the Drugs for Neglected Diseases initiative, issued a statement this week that called on World Health Organization (WHO) member states to strengthen their responses to antimicrobial resistance (AMR).
An analysis of US nursing home surveys shows substantial progress in antibiotic stewardship element implementation, researchers with the Centers for Disease Control and Prevention (CDC) reported today in Infection Control & Hospital Epidemiology.
Antibiotic prescribing for young children in Israel sharply declined following implementation of pneumococcal conjugate vaccine (PCV), Israeli researchers reported today in Clinical Infectious Diseases.
Long-haul COVID-19 was associated with severe or very severe symptoms, low income, and some age-groups, but was common even in those with mild symptoms, with a quarter of patients in that group having symptoms after 60 days, according to a Clinical Infectious Diseases study today that looked at adult Michigan patients.
CARB-X announced today that it is awarding up to $4.1 million to Summit Therapeutics of Cambridge, Massachusetts, to develop a first-in-class antibiotic to treat multidrug-resistant bacterial infections.
COVID-related mobility restrictions such as stay-at-home orders had disproportionate burdens on women, minorities, and lower-income populations, according to a study yesterday in JAMA Network Open.
